Search clinical trials for: Programmed cell death protein (PD-1)
Total 104615 results
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer | Solid Tumors | Programmed Cell Death-1 (PD1, PD-1) | Programmed Cell Death 1 Ligand 1(PDL1, PD-L1) | Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)Japan
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Guohui LiRecruitingPD-1 | Immune Related Adverse EventsChina
-
Shanghai International Medical CenterUnknownAdvanced Solid Tumor | PD-1 Antibody | CAR-T CellsChina
-
Ningbo Cancer HospitalUnknownAdvanced Malignancies | PD-1 Antibody | CAR-T CellsChina
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin LymphomaUnited States, Brazil, Colombia, Czechia, France, Germany, Greece, Guatemala, Italy, Korea, Republic of, Mexico, Netherlands, Slovakia, South Africa, Spain, United Kingdom
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingColorectal NeoplasmsUnited States, Argentina, Australia, Canada, China, Denmark, Germany, Israel, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Peking UniversityNot yet recruitingGastroesophageal Junction Cancer | Chemoradiotherapy | PD-1
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CarcinomaPoland, Russian Federation, United States, Australia, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
Merck Sharp & Dohme LLCCompletedProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
Beijing Friendship HospitalNot yet recruiting
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingAdvanced/Metastatic Gastroesophageal AdenocarcinomaChina, Japan, Poland, Hong Kong, Korea, Republic of, Canada, United States, Argentina, Australia, Belgium, Chile, Colombia, Costa Rica, France, Germany, Guatemala, Ireland, Israel, Italy, Russian Federation, Spain, Taiwan, Turkey, United...
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaSpain, United States, Australia, France, Israel, Italy, South Africa, Switzerland
-
Merck Sharp & Dohme LLCRecruitingUterine Cervical Neoplasms | Stomach Neoplasms | Urinary Bladder Neoplasms | Hepatocellular Carcinoma | Esophageal Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Triple Negative Breast Neoplasms | Gallbladder NeoplasmsUnited States, Chile, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Spain, Taiwan, Turkey, Canada
-
Merck Sharp & Dohme LLCEisai Inc.RecruitingMetastatic Esophageal Squamous Cell CarcinomaArgentina, Chile, United States, Canada, China, Costa Rica, Denmark, France, Guatemala, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, Romania, Ukraine, Singapore, Ma... and more
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced or Metastatic Solid TumorsChile, Hungary, Korea, Republic of, South Africa, Spain, Japan
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCNovartis PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsFrance, Germany, Spain, United Kingdom
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | G-CSFChina
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Head and Neck Neoplasms | Colorectal NeoplasmsAustralia, Hong Kong
-
Merck Sharp & Dohme LLCEisai Inc.RecruitingSquamous Cell Carcinoma of Head and NeckUnited States, Australia, Canada, Denmark, France, Israel, Korea, Republic of, Portugal, Romania, Spain, Taiwan, United Kingdom, Colombia, Brazil, Norway
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Non-Small Cell Lung CancerPoland, Russian Federation, United States, Australia, Canada, Hong Kong, Ireland, Italy, Japan, Korea, Republic of, Singapore, South Africa, Spain, Switzerland, Taiwan, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingEsophageal Squamous Cell Carcinoma (ESCC)Japan, Korea, Republic of, Taiwan, Italy, Thailand, France, Turkey, Brazil, Switzerland, Singapore, Germany, Chile, Norway
-
Merck Sharp & Dohme LLCRecruitingEsophageal Squamous Cell CarcinomaJapan, Korea, Republic of, China, Taiwan, Italy, Switzerland, Brazil, Germany, Singapore, Turkey, Thailand, Chile, Norway
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Australia, Canada, Chile, China, France, Greece, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Sweden
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNon-small Cell Lung CancerChina, Israel, United States, Australia, Canada, Colombia, Estonia, France, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Poland, Russian Federation, Taiwan, Turkey, Ukraine
-
Merck Sharp & Dohme LLCEisai Inc.CompletedAdvanced MelanomaCanada, United States, Australia, Spain, Sweden
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Chile, China, France, Germany, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRenal Cell CarcinomaPoland, Australia, United States, Canada, France, Hungary, Ireland, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CancerPoland, Russian Federation, United States, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
Hunan Cancer HospitalCompleted
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMetastatic Non-Small Cell Lung CancerRussian Federation, Australia, United States, Argentina, Canada, Colombia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Puerto Rico, Spain, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNon-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingRenal Cell CarcinomaUnited States, Australia, Canada, Chile
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaCanada, United States, Australia, Belgium, Brazil, Chile, France, Germany, Israel, Italy, Japan, Poland, South Africa, Spain, Switzerland, United Kingdom
-
Shanghai Zhongshan HospitalRecruiting
-
Merck Sharp & Dohme LLCRecruitingCarcinoma, Non-Small-Cell LungUnited States, Australia, Brazil, Chile, China, Costa Rica, Dominican Republic, Germany, Greece, Guatemala, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Spain, Turkey, Portugal, Romania, South Africa
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)Australia, United States, Turkey, Taiwan, Denmark, France, Spain
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate Cancer
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruiting
-
Merck Sharp & Dohme LLCRecruitingHodgkin LymphomaAustralia, Israel, Korea, Republic of, Spain, Poland, Sweden, United Kingdom, Turkey, China, United States, Brazil, Germany, Belgium, France, Switzerland, Canada, Czechia, Chile, Argentina